APA (7th ed.) Citation

JM, W., Q, Z., Y, Z., F, V., D, H., L, H., . . . E, H. (2025). Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 31(24), 5225. https://doi.org/10.1158/1078-0432.CCR-24-3785

Chicago Style (17th ed.) Citation

JM, Wiggins, et al. "Tumor MiRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 31, no. 24 (2025): 5225. https://doi.org/10.1158/1078-0432.CCR-24-3785.

MLA (9th ed.) Citation

JM, Wiggins, et al. "Tumor MiRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 31, no. 24, 2025, p. 5225, https://doi.org/10.1158/1078-0432.CCR-24-3785.